Repligen deal

The company garnered a windfall of more than $4 million when Sandoz Corp. bought RGEN's 40 percent share of Repligen Sandoz Research Corp. for an undisclosed amount plus a $4 million equity investment (320,000 shares of RGEN common stock at $12.50 per share). The Sandoz shares represent 2.6 percent of RGEN shares outstanding. ...